Novartis to buy US biotech Tourmaline Bio for US$1.4 billion
September 9, 2025
[ad_1] [BERN] Novartis agreed to buy Tourmaline Bio in a deal valued at about US$1.4 billion as the Swiss drugmaker continues to pursue bolt-on deals to boost its drug pipeline. The...
